Quest Diagnostics Income from Discontinued Operations 2010-2024 | DGX

Quest Diagnostics annual/quarterly income from discontinued operations history and growth rate from 2010 to 2024. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
  • Quest Diagnostics income from discontinued operations for the quarter ending September 30, 2024 was $M, a NAN% increase year-over-year.
  • Quest Diagnostics income from discontinued operations for the twelve months ending September 30, 2024 was $0M, a NAN% increase year-over-year.
  • Quest Diagnostics annual income from discontinued operations for 2023 was $0B, a NAN% decline from 2022.
  • Quest Diagnostics annual income from discontinued operations for 2022 was $0B, a NAN% decline from 2021.
  • Quest Diagnostics annual income from discontinued operations for 2021 was $0B, a NAN% decline from 2020.
Quest Diagnostics Annual Income from Discontinued Operations
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $20
2018 $
2017 $
2016 $
2015 $
2014 $5
2013 $35
2012 $-74
2011 $12
2010 $12
2009 $-1
Quest Diagnostics Quarterly Income from Discontinued Operations
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30 $20
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30 $2
2013-06-30 $13
2013-03-31 $20
2012-12-31 $-84
2012-09-30 $5
2012-06-30 $2
2012-03-31 $3
2011-12-31 $13
2011-09-30 $-0
2011-06-30 $-1
2011-03-31 $-0
2010-12-31 $13
2010-09-30 $-0
2010-06-30 $-0
2010-03-31 $-0
2009-12-31 $-0
2009-09-30 $1
2009-06-30 $0
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $18.293B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 11.70
DaVita (DVA) United States $13.459B 17.41
Encompass Health (EHC) United States $10.015B 23.61
Chemed (CHE) United States $8.477B 26.05
Elanco Animal Health (ELAN) United States $6.624B 15.77
RadNet (RDNT) United States $6.018B 133.28
Option Care Health (OPCH) United States $3.827B 18.14
Amedisys (AMED) United States $2.953B 21.02
LifeStance Health (LFST) United States $2.797B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.191B 25.71
U.S Physical Therapy (USPH) United States $1.463B 38.47
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.048B 42.36
Atai Life Sciences (ATAI) Germany $0.255B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.008B 0.00
ATI Physical Therapy (ATIP) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00